Galena Biopharma Inc (NASDAQ:GALE)

Delayed Data
As of Mar 03
 +0.04 / +2.21%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 6.50, with a high estimate of 8.00 and a low estimate of 2.00. The median estimate represents a +251.35% increase from the last price of 1.85.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -125.72%
Growthannually 58.32%


Growthquarterly 56.10%
Growthannually 242.96%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account